🔎 Trials Near Me

Akèy › Migrèn › Illinois › Naperville

Etid klinik pou Migrèn nan Naperville, IL

4 etid pou Migrèn ap chèche patisipan nan sit nan ak bò kote Naperville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Ap rekriteFaz 3
  • AMR-Baber Research Inc, Naperville
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Ap rekriteFaz 3
  • AMR-Baber Research Inc, Naperville
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Ap rekriteFaz 3
  • Chicago Headache Center & Research Institute, Naperville
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Ap rekriteEtid obsèvasyon
  • Chicago Headache Center & Research Inst /ID# 272345, Naperville
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT07310290

Etid Migrèn nan lòt vil

Lòt etid nan Naperville

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.